Skip to main content
SpringerLink
Log in

Ginkgo biloba for Dementia

A Systematic Review of Double-Blind, Placebo-Controlled Trials

  • Clinical Review
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Objective: To systematically review the clinical evidence of Ginkgo biloba preparations as a symptomatic treatment for dementia.

Methods: Computerised literature searches were performed to identify all double-blind, randomised, placebo-controlled trials assessing clinical end-points of Ginkgo biloba extract as a treatment for dementia. Databases included Medline, Embase, Biosis and the Cochrane Library. There were no restrictions regarding the language of publication. Data were extracted in a standardised, predefined fashion, independently by both authors.

Results: Nine double-blind, randomised, placebo-controlled trials met the inclusion criteria and were reviewed. These studies are of varying methodological quality. They collectively suggest that Ginkgo biloba extract is more effective for dementia than placebo. However, a number of caveats pertain. Few, generally mild, adverse effects were reported.

Conclusion: These findings are encouraging and warrant independent, large scale confirmatory and comparative trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fisher P, Ward A. Complementary medicine in Europe. BMJ 1994; 309: 107–11

    Article  PubMed  CAS  Google Scholar 

  2. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998; 279: 1548–53

    Article  PubMed  CAS  Google Scholar 

  3. Häussermann D. Wachsendes Vertrauen in Naturheilmittel. Dtsch Ärztebl 1997; 94: 1857–8

    Google Scholar 

  4. Ernst E, editor. Complementary medicine: an objective appraisal. Oxford: Butterworth, 1996

    Google Scholar 

  5. Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997; 278: 1327–32

    Article  Google Scholar 

  6. Jadad AR, Moore RA, Carrol D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996; 17: 1–12

    Article  PubMed  CAS  Google Scholar 

  7. Eckmann F, Schlag H. Kontrollierte Doppelblind-Studies zum Wirksamkeitsnachweis von Tebonin forte bei Patienten mit zerebrovaskulärer Insuffizienz. Fortschr Med 1982; 100: 1474–8

    PubMed  CAS  Google Scholar 

  8. Halama P, Bartsch G, Meng G. Hirnleistungsstörungen vaskulärer Genese. Fortschr Med 1988; 106: 408–12

    PubMed  CAS  Google Scholar 

  9. Kleijnen J, Knipschild R Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992; 34: 352–8

    Article  PubMed  CAS  Google Scholar 

  10. Vesper J, Hänsgen K-D. Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age. Phyto-medicine 1994; 1: 9–16

    Article  Google Scholar 

  11. Eckmann F. Behandlung von Hirnleistungsstörungen mit Ginkgo biloba Extrakt. Fortschr Med 1990; 108: 557–60

    PubMed  CAS  Google Scholar 

  12. Vorberg G, Schenk N, Schmidt U. Wirksamkeit eines neuen Ginkgo-biloba-Extrakes bei 100 Patienten mit zerebraler Insufizienz. Herz Gefässe 1989; 7: 3–8

    Google Scholar 

  13. Gerhardt G, Rogalla K, Jaeger J. Medikamentöse Therapie von Hirnleistungsstörungen. Fortschr Med 1990; 108: 384–8

    PubMed  CAS  Google Scholar 

  14. Taillandier J, Ammar A, Rabourdin JP, et al. Traitement des troubles du vieillissement cérébral par l’extrait de Ginkgo biloba. Etude longitudinale multicentrique à double insu face au placebo. Presse Méd 1986; 15: 1583–7

    PubMed  CAS  Google Scholar 

  15. Hofferberth B. Einfluss von Ginkgo biloba-Extrakt auf neurophysiologische und psychometrische Messergebnisse bei Patienten mit hirnorganischem Psychosyndrom. Arzneimittel Forschung 1989; 39: 918–22

    PubMed  CAS  Google Scholar 

  16. Kanowski S, Herrmann WM, Stephan K, et al. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 1996; 29: 47–56

    Article  PubMed  CAS  Google Scholar 

  17. Weitbrecht W-U, Jansen W. Ginkgo biloba extract in the treatment of primary degenerative dementia. Placebo-controlled, double-blind and comparative study. Fortschr Med 1986; 104: 199–202

    PubMed  CAS  Google Scholar 

  18. Hartmann A, Frick M. Wirkung eines Ginkgo-spezial-extraktes auf psychometrische Parameter bei Patienten mit vaskulär bedingter Demenz. Münch Med Wochenschr 1991; 133Suppl. 1: 23–5

    Google Scholar 

  19. Halama P. Befindlichkeitsbeurteilung und Psychometrie. Testung der Ginkgo-biloba-Wirkung bei Patienten einer Neurologischen Fachpraxis. Münch Med Wochenschr 1991; 133Suppl. 1: 19–22

    Google Scholar 

  20. Hofferberth B. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo-controlled study on different levels of investigation. Hum Psychopharm 1994; 9: 215–22

    Article  Google Scholar 

  21. Maurer K, Ihl R, Dierks T, et al. Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type. J Psychiatr Res 1997; 31: 645–55

    Article  PubMed  CAS  Google Scholar 

  22. Mancini M, Agozzino B, Bompani ER. Effetti clinico-terapeutici dell’estratto di Ginkgo biloba (EGb) in confronto a placebo, nel trattamento di pazienti affetti da demenza psicorganica senile su base arteriosclerotica. Gazz Med Ital Arch Sci Med 1993; 152: 69–80

    Google Scholar 

  23. Haase J, Halama P, Hörr R. Efficacy of short-term treatment with intravenously administered Ginkgo biloba special extract EGb 761 in Alzheimer type and vascular dementia. Z Gerontol Geriatr 1996; 29: 302–9

    PubMed  CAS  Google Scholar 

  24. Martindale The Extra Pharmacopoeia. 31st ed. London: Royal Pharmaceutical Society, 1996

  25. Blumenthal M, editor. The complete German Commission E Monographs. Austin,Texas: American Botanical Council, 1998

    Google Scholar 

  26. DeFeudis TV. Ginkgo biloba extract (EGinkgo biloba 761): pharmacological activities and clinical application. Paris: Elsevier, 1991

    Google Scholar 

  27. Reuter HD. Ginkgo biloba —botany, constituents, pharmacology, and clinical trials. Br J Phytother 1995/96; 4: 3–20

    Google Scholar 

  28. Ernst E, Matrai A. Hämorheologische in-vitro Effekte von Ginkgo biloba. Herz Kreislauf 1986; 18: 350–60

    Google Scholar 

  29. Ernst FD. Wirkung eines Ginkgo-biloba Spezialextraktes auf die gestörte MikroZirkulation. Münch Med Wochenschr 1991; 133Suppl. 1: S51–3

    Google Scholar 

  30. Kobuchi H, Droy Lefaix MT, Christen Y, et al. Ginkgo biloba extract (EGinkgo biloba 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264.7. Biochem Pharmacol 1997; 53: 897–903

    Article  PubMed  CAS  Google Scholar 

  31. Burkard G, Lehrl S. Verhältnis von Demenzen vom Multiinfarkt-und vom Alzheimertyp in ärztlichen Praxen. Diagnostische und therapeutische Konsequenzen am Beispiel eines Ginkgo-biloba-Präparates. Münch Med Wochenschr 1991; 133 Suppl. 1: 38–43

    Google Scholar 

  32. Ernst E. Placebo forte. Wien Med Wochenschr 1992; 142: 217–9

    PubMed  CAS  Google Scholar 

  33. Ernst E, DeSmet PA, Shaw D, et al. Traditional remedies and the test of time. Eur J Clin Pharmacol 1998; 54: 99–100

    Article  PubMed  CAS  Google Scholar 

  34. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46: 1775–6

    Article  PubMed  CAS  Google Scholar 

  35. Rosenblatt M, Mindel J.Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997; 10: 1108

    Article  Google Scholar 

  36. Chung KF, Dent G, McCusker M, et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. Lancet 1987; 1: 248–51

    Article  PubMed  CAS  Google Scholar 

  37. Stacker O, Pons C, Duverger JP, et al. Effect of Ginkgo biloba extract (EGinkgo biloba 761) on the vasospastic response of mouse cutaneous arterioles to platelet activation. Int J Microcirc Clin Exp 1997; 17: 61–6

    Article  Google Scholar 

  38. Itil TM, Eralp E, Tsambis E, et al. Central nervous system effects of Ginkgo biloba, a plant extract. Am J Ther 1996; 3: 63–73

    Article  PubMed  Google Scholar 

  39. Kleijnen J, Knipschild P. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 1992; 34: 352–8

    Article  PubMed  CAS  Google Scholar 

  40. Hopfenmüller W Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age. Arzneimittel Forschung 1994; 44: 1005–13

    PubMed  Google Scholar 

  41. Ernst E. Ginkgo biloba in der Behandlung der Claudicatio intermittens. Fortschr Med 1996; 8: 25–7

    Google Scholar 

  42. Chant HJ, Thompson J. Ginkgo biloba in end stage peripheral arterial disease. Perfusion 1997; 7: 240

    Google Scholar 

  43. Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet 1991; 337: 867–72

    Article  PubMed  CAS  Google Scholar 

  44. Ernst E, Pittler MH. Alternative therapy bias. Nature 1997; 385: 480

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Complementary Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, 25 Victoria Park Road, Exeter, EX2 4NT, England

    E. Ernst & M. H. Pittler

Authors
  1. E. Ernst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. H. Pittler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Ernst.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ernst, E., Pittler, M.H. Ginkgo biloba for Dementia. Clin. Drug Investig. 17, 301–308 (1999). https://doi.org/10.2165/00044011-199917040-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-199917040-00006

Keywords

Search

Navigation